BDBM102132 US8530648, 29

SMILES: O=C1N(Cc2cccc3ccccc23)CCCC11CCN(CC1)c1cnc2ccccc2n1

InChI Key: InChIKey=VIOJTUUTJMPSRP-UHFFFAOYSA-N

Data: 2 KI  2 Kd

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 102132   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Orexin receptor type 2 (Homo sapiens (Human))	BDBM102132 (US8530648, 29) Show SMILES O=C1N(Cc2cccc3ccccc23)CCCC11CCN(CC1)c1cnc2ccccc2n1 Show InChI InChI=1S/C28H28N4O/c33-27-28(13-6-16-32(27)20-22-9-5-8-21-7-1-2-10-23(21)22)14-17-31(18-15-28)26-19-29-24-11-3-4-12-25(24)30-26/h1-5,7-12,19H,6,13-18,20H2	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	30	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Novartis AG US Patent					Assay Description FLIPR assay using orexin receptor.				US Patent US8530648 (2013) BindingDB Entry DOI: 10.7270/Q2SB44DR
					More data for this Ligand-Target Pair
Orexin receptor type 1 (Homo sapiens (Human))	BDBM102132 (US8530648, 29) Show SMILES O=C1N(Cc2cccc3ccccc23)CCCC11CCN(CC1)c1cnc2ccccc2n1 Show InChI InChI=1S/C28H28N4O/c33-27-28(13-6-16-32(27)20-22-9-5-8-21-7-1-2-10-23(21)22)14-17-31(18-15-28)26-19-29-24-11-3-4-12-25(24)30-26/h1-5,7-12,19H,6,13-18,20H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	482	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Novartis AG US Patent					Assay Description FLIPR assay using orexin receptor.				US Patent US8530648 (2013) BindingDB Entry DOI: 10.7270/Q2SB44DR
					More data for this Ligand-Target Pair
Orexin receptor type 2 (Homo sapiens (Human))	BDBM102132 (US8530648, 29) Show SMILES O=C1N(Cc2cccc3ccccc23)CCCC11CCN(CC1)c1cnc2ccccc2n1 Show InChI InChI=1S/C28H28N4O/c33-27-28(13-6-16-32(27)20-22-9-5-8-21-7-1-2-10-23(21)22)14-17-31(18-15-28)26-19-29-24-11-3-4-12-25(24)30-26/h1-5,7-12,19H,6,13-18,20H2	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	34	n/a	n/a	n/a	7.5	n/a
Novartis AG US Patent					Assay Description Radioligand binding assay using orexin receptor.				US Patent US8530648 (2013) BindingDB Entry DOI: 10.7270/Q2SB44DR
					More data for this Ligand-Target Pair
Orexin receptor type 1 (Homo sapiens (Human))	BDBM102132 (US8530648, 29) Show SMILES O=C1N(Cc2cccc3ccccc23)CCCC11CCN(CC1)c1cnc2ccccc2n1 Show InChI InChI=1S/C28H28N4O/c33-27-28(13-6-16-32(27)20-22-9-5-8-21-7-1-2-10-23(21)22)14-17-31(18-15-28)26-19-29-24-11-3-4-12-25(24)30-26/h1-5,7-12,19H,6,13-18,20H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	360	n/a	n/a	n/a	7.5	n/a
Novartis AG US Patent					Assay Description Radioligand binding assay using orexin receptor.				US Patent US8530648 (2013) BindingDB Entry DOI: 10.7270/Q2SB44DR
					More data for this Ligand-Target Pair